Evolution of ischemic stroke drug clinical trials in mainland China from 2005 to 2021
Chunrui Bo(Harbin Medical University), Hongyan Li(Hebei Medical University), Lihua Wang(Jiangxi University of Traditional Chinese Medicine), Lixia Chen(Shanxi University of Traditional Chinese Medicine), Tianqi Wang(Shandong Provincial Hospital), Jinming Han(Jilin University), Chengbei Hou(Capital Medical University), Huixue Zhang(Harbin Medical University)
Cited by 11
Related Papers
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
|New England Journal of Medicine|2022|707
Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers
|Nucleic Acids Research|2015|386
The mRNA related ceRNA–ceRNA landscape and significance across 20 major cancer types
|Nucleic Acids Research|2015|209
Modulating influence on HIV/AIDS by interacting <i>RANTES</i> gene variants
|Proceedings of the National Academy of Sciences|2002|189
Rational Design and Synthesis of Novel Dual PROTACs for Simultaneous Degradation of EGFR and PARP
|Journal of Medicinal Chemistry|2021|186